Urothelial Carcinoma With Loss of SMARCA4 Expression With the Site of Origin Identified by Detailed Autopsy Investigation
- 2 September 2026
- journal article
- Published by Wiley in Pathology International
- Vol. 76 (9)
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (JP256f0137006)
This publication has 5 references indexed in Scilit:
- Case Report: Recognition and management of SMARCA4-deficient renal cell carcinomaFrontiers in Oncology, 2025
- Clinical Characteristics and Outcomes of SMARCA4-Mutated or Deficient Malignancies: A Systematic Review of Case Reports and SeriesCancers, 2025
- The SWI/SNF complex in cancer — biology, biomarkers and therapyNature Reviews Clinical Oncology, 2020
- Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancersNature Structural & Molecular Biology, 2017
- Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tractVirchows Archiv, 2016